Veradermics MANE Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's change in accrued liabilities?
- Veradermics (MANE) reported change in accrued liabilities of -$1.37M in Q1 2026.
- How has Veradermics 's change in accrued liabilities changed year-over-year?
- Veradermics 's change in accrued liabilities decreased by 59.3% year-over-year, from -$862K to -$1.37M.
- What does change in accrued liabilities mean?
- The change in expenses incurred but not yet paid in cash.
- How do you interpret change in accrued liabilities?
- An increase suggests the company is deferring cash payments, while a decrease indicates a reduction in outstanding obligations.
- How does change in accrued liabilities compare across companies?
- Standard operational metric for assessing short-term debt management.